Similar articles

• Molecular advances in understanding inherited prion diseases.

  Brown DR. Brown DR. Mol Neurobiol. 2002 Jun;25(3):287-302. doi: 10.1385/MN:25:3:287. Mol Neurobiol. 2002. PMID: 12109876 Review.
• Folding and misfolding of the prion protein in the secretory pathway.

  Tatzelt J, Winklhofer KF. Tatzelt J, et al. Amyloid. 2004 Sep;11(3):162-72. doi: 10.1080/1350-6120400000723. Amyloid. 2004. PMID: 15523918 Review.
• A transmembrane form of the prion protein in neurodegenerative disease.

  Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, DeArmond SJ, Prusiner SB, Lingappa VR. Hegde RS, et al. Science. 1998 Feb 6;279(5352):827-34. doi: 10.1126/science.279.5352.827. Science. 1998. PMID: 9452375
• Prions and prion diseases.

  Pergami P, Poloni TE, Corato M, Camisa B, Ceroni M. Pergami P, et al. Funct Neurol. 1999 Oct-Dec;14(4):241-52. Funct Neurol. 1999. PMID: 10713898 Review. No abstract available.
• Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.

  Telling GC, Scott M, Mastrianni J, Gabizon R, Torchia M, Cohen FE, DeArmond SJ, Prusiner SB. Telling GC, et al. Cell. 1995 Oct 6;83(1):79-90. doi: 10.1016/0092-8674(95)90236-8. Cell. 1995. PMID: 7553876